Xtera Takes Legal Action Against Nokia and NEC
Xtera, a provider of subsea fiber optic solutions, has initiated legal action against Nokia, including Alcatel-Lucent, and NEC in order to halt infringement of its intellectual property in subsea telecommunications systems.
Xtera has filed a complaint with the U.S. International Trade Commission (ITC) alleging that Nokia and NEC are using its technology illegally and without permission, and seeking to prevent the companies from importing and selling in the U.S. products that infringe on Xtera’s patents.
Namely, Xtera believes that Nokia and NEC market and sell products that incorporate patent-protected technologies developed by Xtera without license to do so. These products include submarine line terminal equipment and components that are needed to transport optical signals across the ocean.
Keith Henderson, founder and chief operating officer of Xtera, said: “Xtera’s investment in R&D, commitment to innovation, and focus on providing high-quality solutions to customers have always been, and will always be, at the core of our strategy. Our relentless pursuit of that strategy has transformed the subsea telecommunications industry, helping to enable the effective and efficient transmission of data across continents and around the world. We are proud of our achievements and our role as an industry pioneer, and we cannot allow our competitors to unfairly, and illegally, take advantage of our technology. By initiating legal action, Xtera is not only taking steps to protect what is lawfully ours, but we are also helping to ensure that innovation and intellectual property, which are essential to scientific advancement, are appropriately safeguarded.”
Xtera has asked the ITC to issue a permanent, limited exclusion order that would prevent entry into the U.S. of products that infringe on Xtera’s patents. The company also seeks a permanent cease and desist order that prohibits Nokia and NEC from importing, selling, distributing, marketing and/or advertising, and transferring any products within the U.S. that infringe on Xtera’s asserted U.S. patents.